Alpha Cognition (ACOG) Assets Average (2024 - 2025)
Alpha Cognition's (ACOG) quarterly Assets Average came in at $63.0 million in Q4 2025, up 126.0% year-on-year from $27.9 million in Q4 2024, and up 37.85% quarter-over-quarter from $45.7 million in Q3 2025.
Alpha Cognition (ACOG) Assets Average (2024 - 2025) Analysis & Trends
Alpha Cognition's Assets Average history runs 2 years deep, the most recent figure standing at $63.0 million for Q4 2025.
- On a quarterly basis, Assets Average rose 126.0% year-over-year to $63.0 million in Q4 2025; TTM through Dec 2025 was $63.0 million, a 126.0% increase from a year earlier, with the FY2025 full-year figure at $65.2 million, up 145.29% from the prior year.
- Assets Average advanced to $63.0 million in Q4 2025 per ACOG's latest filing, from $45.7 million in the prior quarter.
- Across five years, Assets Average topped out at $63.0 million in Q4 2025 and bottomed at $3.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 63.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.02 Mn |
| Sep 30, 2025 | 45.71 Mn |
| Jun 30, 2025 | 46.87 Mn |
| Mar 31, 2025 | 49.67 Mn |
| Dec 31, 2024 | 27.88 Mn |
| Sep 30, 2024 | 3.56 Mn |